All Products

39-amino acid peptide evaluated in laboratory assays involving GIP, GLP-1, and glucagon receptor pathways.

Dual GIP/GLP-1 receptor agonist peptide.

Synthetic 15-residue gastric pentadecapeptide.

Copper(II) tripeptide-1 complex.

Sterile reconstitution diluent, 0.9% benzyl alcohol.

Nicotinamide adenine dinucleotide, oxidized.

Thymosin beta-4 active fragment.

GHK-Cu, BPC-157, TB-500 and KPV co-formulation.

16-residue mitochondrial-derived peptide.

Elamipretide, mitochondria-targeted tetrapeptide.

C-terminal alpha-MSH tripeptide.

Reduced L-glutathione tripeptide.

Heptapeptide tuftsin analog.

ACTH (4-10) analog heptapeptide.

Semax in nasal research format.

Small-molecule methylquinolinium research compound.

83-residue recombinant IGF-1 analog.

Co-formulated BPC-157 and TB-500 blend.

GHK-Cu, BPC-157 and TB-500 co-formulation.

Long-acting amylin analog.

Mod GRF (1-29) and ipamorelin blend.

Trans-3-hexenoyl GHRH (1-44) analog.

Pentapeptide studied for receptor-signaling activity in laboratory research.

Modified GRF (1-29) secretagogue analog.

Tesamorelin and ipamorelin blend.

HGH fragment 176-191 analog.

Bremelanotide, cyclic heptapeptide analog.

Cyclic nonapeptide with disulfide bridge.

Kisspeptin-10 decapeptide.

Kisspeptin-10 in nasal research format.

Cyclic lactam alpha-MSH analog.

GHRH (1-29) amide, 29 residues.

Synthetic tetrapeptide Ala-Glu-Asp-Gly.

Thymosin alpha-1, 28 residues.

Nonapeptide studied in laboratory neuroendocrine research.

37-residue cathelicidin-derived peptide.

Vasoactive intestinal peptide, 28 residues.

24-residue mitochondrial-derived peptide.

11-residue erythropoietin-derived peptide.

Synthetic tripeptide Glu-Asp-Arg.

FOXO4-p53 interfering peptide, D-retro-inverso.

Research peptide preparation, lyophilized.